The 10-second takeaway
For the quarter ended March 31 (Q1), Insulet met expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly. GAAP loss per share contracted.
Margins expanded across the board.
Insulet notched revenue of $57.4 million. The 15 analysts polled by S&P Capital IQ foresaw a top line of $57.3 million on the same basis. GAAP reported sales were 20% higher than the prior-year quarter's $47.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.20. The 16 earnings estimates compiled by S&P Capital IQ predicted -$0.21 per share. GAAP EPS were -$0.20 for Q1 compared to -$0.31 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 43.9%, 140 basis points better than the prior-year quarter. Operating margin was -10.8%, much better than the prior-year quarter. Net margin was -18.6%, much better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $60.8 million. On the bottom line, the average EPS estimate is -$0.19.
Next year's average estimate for revenue is $248.1 million. The average EPS estimate is -$0.59.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 67 members out of 109 rating the stock outperform, and 42 members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Insulet a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Insulet is outperform, with an average price target of $25.38.
Is Insulet the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Insulet to My Watchlist.